"Despite an earlier setback with bifeprunox, three new antipsychotic drugs — asenapine [molecular structure illustrated on right], paliperidone palmitate injection, and iloperidone — have been submitted to the FDA for review."To read this article written by Jun Yan and published in the January 4th issue of Psychiatric News, click here.
No comments:
Post a Comment